Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 77.00
+3.00 (4.05%)
Sep 4, 2026, 3:29 PM GMT
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 28.88 million as of September 4, 2026. Its market cap has increased by 14.18% in one year.
Market Cap
28.88M
Enterprise Value
22.85M
Revenue
1.71M
Ranking
n/a
PE Ratio
38.25
Stock Price
77.00
ChartMarket Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 28.88M, a decrease of -56.89%. That is a compound annual growth rate of -14.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 28.88M | -4.97% |
| Dec 31, 2025 | 30.39M | 9.52% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Poolbeg Pharma | 65.66M |
| Ondine Biomedical | 62.35M |
| hVIVO | 46.72M |
| Sareum Holdings | 46.42M |
| Hemogenyx Pharmaceuticals | 38.42M |
| SkinBioTherapeutics | 24.62M |
| ImmuPharma | 21.84M |
| IXICO | 16.90M |